Clinical trial
Revlimid 5 mg Capsules Special Use-results Surveillance of Long Term Use
NCT02922543 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Revlimid 5 mg Capsules Special Use-results Surveillance of Long Term Use
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 18, 2011
- Completion date
- October 11, 2014
- Enrollment
- 361 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.